These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 996983)

  • 21. Leukocyte migration inhibition (LMI) by a specific antigen in human toxoplasmosis.
    Ferencz A; Nyerges G; Jankó M
    Acta Microbiol Acad Sci Hung; 1982; 29(3):209-11. PubMed ID: 7168371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human cell-mediated immunity to tuberculin as assayed by the agarose micro-droplet leukocyte migration inhibition technique: comparison with the capillary tube assay.
    McCoy JL; Dean JH; Herberman RB
    J Immunol Methods; 1977; 15(4):355-71. PubMed ID: 874326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-effect relationship between tuberculin concentration and tuberculin-induced migration inhibition of human peripheral blood leukocytes demonstrated by agarose migration technique.
    Clausen JE
    Acta Allergol; 1973 Sep; 28(3):159-71. PubMed ID: 4800882
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of skin testing on cellular immunity as measured in vitro by leukocyte migration inhibition.
    Ramsey EW; Brandes LJ; Goldenberg GJ
    Cell Immunol; 1977 Apr; 30(1):156-61. PubMed ID: 862033
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of leukocyte aggregation, leukocyte migration and skin reactivity to recall antigens in patients with AIDS.
    Rouveix B; Groult F; Pocidalo JJ
    Clin Exp Immunol; 1986 Dec; 66(3):574-81. PubMed ID: 3568448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukocyte migration inhibition in vitro in untreated and methimazole-treated patients with Graves disease.
    Kálmán K; Fazakas S; Erdei I; Leövey A
    Acta Med Acad Sci Hung; 1976; 33(4):327-32. PubMed ID: 1037636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human leukocyte migration inhibition as an indicator of cellular hypersensitivity to soluble antigens.
    Rauch HC; King K
    Int Arch Allergy Appl Immunol; 1973; 44(6):862-74. PubMed ID: 4199134
    [No Abstract]   [Full Text] [Related]  

  • 28. Migration inhibitory effect of cell-free supernatants from tuberculin-stimulated cultures of human mononuclear leukocytes demonstrated by two-step MIF agarose assay.
    Clausen JE
    J Immunol; 1973 Feb; 110(2):546-51. PubMed ID: 4684036
    [No Abstract]   [Full Text] [Related]  

  • 29. [Leukocyte migration test. Possibilities of its use in pediatrics].
    Clot J; Astruc J; Brunel D
    Pediatrie; 1972 Mar; 27(2):139-47. PubMed ID: 5043547
    [No Abstract]   [Full Text] [Related]  

  • 30. Cell-mediated response to BCG investigated by leukocyte migration test from an agarose droplet.
    Krystůfková O; Hausner P; Janatková I; Votava V; Sebes A
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):181-7. PubMed ID: 3411120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular immunity in man assessed by indirect migration inhibition test using murine spleen leukocytes.
    Górski A; Madalińska M; Droszcz W
    Biomedicine; 1973 Jan; 19(1):19-21. PubMed ID: 4575691
    [No Abstract]   [Full Text] [Related]  

  • 32. Cellular immunity in man assessed by indirect migration inhibition test using murine spleen leukocytes.
    Górski A; Madalinska M; Droszcz W
    Biomedicine; 1973 Jan; 19(1):19-21. PubMed ID: 4593322
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunological peculiarities of sarcoidosis].
    Gallopin Y
    Rev Med Suisse Romande; 1975 Jan; 95(1):21-42. PubMed ID: 1118702
    [No Abstract]   [Full Text] [Related]  

  • 34. Immune reactivity in subjects remaining tuberculin-negative after repeated BCG vaccination.
    Szabó G; Szegedi G; Kovács L; Gergely P; Fekete B; Petrányi G
    Acta Med Acad Sci Hung; 1976; 33(1):51-61. PubMed ID: 1023736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular interactions in the leukocyte migration inhibition system.
    Read SE; Zabriskie JB
    Transplant Proc; 1972 Jun; 4(2):247-52. PubMed ID: 5034151
    [No Abstract]   [Full Text] [Related]  

  • 36. [Leukocyte migration test in the presence of P.P.D. tuberculin].
    Clot J; Elharrar S; Mandin J
    Nouv Presse Med; 1972 Mar; 1(11):750. PubMed ID: 5022255
    [No Abstract]   [Full Text] [Related]  

  • 37. [New data concerning sarcoidosis immunology].
    Ispasiu M
    Ftiziologia; 1973; 22(3):251-60. PubMed ID: 4576114
    [No Abstract]   [Full Text] [Related]  

  • 38. The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects.
    Velardi A; Rambotti P; Cernetti C; Spinozzi F; Bertotto A; Martelli MF
    Thymus; 1983 Sep; 5(5-6):429-32. PubMed ID: 6362105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human leukocyte migration in agarose by KC1 extracts of lung cancer.
    Boddie AW; Holmes EC; Roth JA
    Surg Forum; 1974; 25(0):109-10. PubMed ID: 4439134
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes in the immunological indices during the antibacterial and pathogenetic therapy of pulmonary tuberculosis].
    Spesivtsev OG; Telkova GV; Gal'chanskaia LD; Sobolevskaia LI
    Probl Tuberk; 1980 Sep; (9):34-8. PubMed ID: 7422654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.